T

Transcat

Calibration services and test equipment distributor

Business Development Manager

Full-TimeDeadline 8/26/27
$75k - $85k/yr+ Commission
Senior
Bachelor's
San Diego, CA, USA
RemoteRegular travel within the region is required; infrequent national travel may be needed.
Sales & Account ManagementField Sales

About the job

Requirements
  • A customer-centric mindset and strong relationship-building ability.
  • Strong oral and written communication skills with exceptional rapport and relationship-building skills.
  • Developed sales skills emphasizing thorough and accurate customer needs assessments, solution development, and gaining and maintaining customer commitment.
  • Effective negotiating skills.
  • Ability to sell to multiple levels and constituencies within customer organizations.
  • Ability to develop and implement comprehensive territory sales plans with clearly defined objectives, strategies, and tactics.
  • Ability to analyze data and draw meaningful insights.
  • A Bachelor's degree in business, marketing, or a related field.
  • At least 5 years of successful experience in customer retention, account management, or a related customer-centric role.
  • Experience with customer relationship management software, such as Salesforce, and data analysis tools.
  • Strong understanding of the company's products and services, or the ability to quickly learn and absorb new technical information.
  • Regular travel within the assigned region and infrequent national travel as needed.
  • Ability to meet the stated physical demands of the role and perform its essential functions.
  • Successful completion of pre-employment requirements, including identity and employment eligibility verification and, when applicable, a motor vehicle driving record report.
Responsibilities
  • Develop and execute regional customer retention and growth strategies aligned with company revenue and Service channel sales goals.
  • Engage current, new, and at-risk regional customers through face-to-face interactions and personalized communication.
  • Analyze customer and regional business data to identify risks, trends, and opportunities to expand revenue within current and new service tracks.
  • Identify customer and regional sector needs, opportunities, and pain points to support relationship expansion and Service track growth.
  • Build and maintain strong relationships with key customers and prospects through consistent, personalized attention, engagement, and service.
  • Address customer concerns and questions promptly and effectively to ensure customer satisfaction.
  • Collaborate with Operations, Customer Service Coordinators, product development, and marketing to improve customer experience and facilitate ease of doing business.
  • Identify and implement initiatives that enhance customer loyalty and satisfaction.
  • Gather and analyze customer feedback to inform continuous improvement efforts.
  • Analyze each lab's regional market, competitive landscape, market trends, and competitive activity to identify new opportunities.
  • Identify and pursue new market opportunities, customer segments, and Service channels.
  • Develop and execute new customer sales strategies across Transcat's portfolio of Service offerings.
  • Use discretion to pursue leads in the assigned region or transfer them to the lab's Account Development Manager.
  • Maintain positive relationships and regular communication with Service Managers through lab visits and knowledge transfer.
  • Visit customers and prospective customers with the Service Manager to build customer intimacy and loyalty and showcase technical knowledge.
  • Advise the Service Manager on sales strategies and results and collaborate on modified and new customer retention and growth approaches.
  • Partner with the Service Manager, Account Development Manager, and Customer Service Representative to maximize customer service, current-customer expansion, and new-customer acquisition.
  • Participate in monthly and quarterly internal lab reviews with Sales and Operations leadership.
  • Report the current state of the lab's customer and regional portfolio and projected wins and revenue to executive team members.
  • Use Salesforce to manage leads, track customer interactions and sales performance, identify trends, make data-driven decisions, and generate reports on sales and market metrics.
  • Maintain accurate, complete, and consistent Salesforce data through data cleaning, updating, and maintenance.
  • Prepare and present regular oral and written reports on retention, growth, new business, channel performance, and opportunities.
  • Manage sales activities in assigned geographic markets and provide feedback to Service Managers, Account Development Managers, and Customer Service Representatives on sales approaches and efforts.
  • Provide coaching, guidance, and support to team members.
  • Motivate and inspire the team to achieve retention, customer growth, and channel goals.
  • Model the company's values to influence aligned performance.
  • Perform other duties as assigned.
Desired Qualifications
  • Experience in a related industry, such as telecommunications, software as a service, or e-commerce.
  • Experience with customer success platforms.
  • Project management skills.
  • Miller Heiman Strategic Selling and Large Account Management Training or Certification.

About the company

Transcat provides calibration services and distributes test and measurement equipment across North America. It began as a tool manufacturer, then became a distributor, and later focused on high-value services by opening calibration labs to ensure instruments meet precise standards. Their products and services work by calibrating instruments in trusted labs to national or industry standards, offering traceable, documented calibration results and related support. The company differentiates itself through a nationwide service network and growth via strategic acquisitions, expanding its geographic reach and technical capabilities in tightly regulated sectors such as life sciences, aerospace, and energy. Its goal is to help customers maintain accurate, compliant measurement tools and equipment, enabling reliable operations in highly regulated industries.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Town of Ogden, New York

Founded

1964

Get referred to Transcat

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 31, 2026 Southeastern Biomedical adds Southeast hospital access and $12.8 million revenue.
  • Q2 2026 revenue reached $92.95 million, beating estimates by 7.4%.
  • Fiscal 2026 service revenue grew 27%; management targets high-single-digit organic growth.

What critics are saying

  • Q2 2026 operating margin fell to 4.0% while acquisition costs swelled.
  • NLRB case 08-RC-382422 opened March 6, 2026 at Mentor, Ohio, signaling labor pressure.
  • Essco, Martin, and SCM loaded Transcat with goodwill; one integration miss triggers impairment risk.

What makes Transcat unique

  • Transcat’s ISO 17025 labs and field service network span North and Central America.
  • Essco, Martin, and SCM gave Transcat calibration density in New England and Costa Rica.
  • Biomedical, aerospace, and energy customers need Transcat’s accredited, regulated-market turnaround times.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Tuition Reimbursement

Employee Stock Purchase Plan

Paid Vacation

Flexible Work Hours

Training Programs

Growth & Insights and Company News

Headcount

6 month growth

13%

1 year growth

13%

2 year growth

13%
BridgeTower Media
Sep 1st, 2026
Transcat expands biomedical business with $12.8M acquisition.

Transcat expands biomedical business with $12.8M acquisition. Rochester-based Transcat Inc. is expanding its biomedical calibration business into the southeastern U.S. with the $12.8 million acquisition of a North Carolina company that serves hospitals and health care facilities. Transcat announced this week that it acquired privately held Southeastern Biomedical Associates Inc. The purchase price was paid in cash and is subject to customary adjustments and holdback provisions. Founded in 1996 and based in Granite Falls, North Carolina, Southeastern provides calibration, repair, preventive maintenance, electrical safety inspections, documentation and regulatory compliance services to hospital networks and other health care facilities throughout the Southeast and beyond. The company also sells biomedical equipment, patient-ready accessories and equipment parts. Its services include helping customers acquire equipment and liquidate assets. The acquisition builds on Transcat's existing biomedical business while expanding its geographic reach in a market the company expects to grow, according to company leaders. For Transcat, the deal is part of a broader strategy to build scale in highly regulated industries where equipment failures can carry significant financial, operational and safety consequences. "The acquisition of Southeastern Biomedical reinforces Transcat's strategy of deepening our presence in the Life Science sector, one of the most regulated and mission-critical end markets we serve," said Jaime Irick, Transcat's president and CEO. Transcat has more than 30 calibration laboratories across North and Central America. The company sees that footprint as a competitive advantage as hospital networks and other regulated customers increasingly need consistent, accredited calibration services across multiple locations. Irick said Southeastern's reputation and customer base will allow Transcat to serve a larger geography while maintaining its focus on quality and turnaround times. The acquisition also brings Southeastern's employees and owners into Transcat. Co-owners Boyd Campbell and Greg Johnson will join the company. Southeastern has built its business over more than three decades serving customers throughout the Southeast and beyond, Johnson said. He said Transcat was the right partner to support the company's next phase of growth. "Transcat has developed a reputation in this industry for treating acquired employees and customers right," Johnson said, adding that he and Campbell look forward to being part of the future of Transcat Biomedical. The acquisition comes as Transcat continues to emphasize mergers and acquisitions as part of its growth strategy. Irick said the combination should create opportunities to expand service across the companies' customer bases while maintaining what he described as industry-leading turnaround times.

MEDQOR
Aug 31st, 2026
Transcat acquires Southeastern Biomedical.

Transcat acquires Southeastern Biomedical. The acquisition expands Transcat's biomedical service footprint across the Southeast, including calibration, repair, and preventive maintenance for healthcare facilities. Transcat has acquired Southeastern Biomedical Associates for $12.8 million in cash, effective Aug 31, 2026. The acquisition expands Transcat's accredited biomedical calibration, equipment repair, and preventive maintenance services throughout the southeastern United States. Based in Granite Falls, NC, Southeastern Biomedical Associates provides calibration, repair, electrical safety inspection, and regulatory compliance services to hospital networks and healthcare facilities. The company's services conform to both ISO/IEC 17025 and ISO 9001 standards. In addition to service, the company sells biomedical equipment, patient-ready accessories, and equipment parts. The acquisition is intended to build scale in regulated end markets where accredited calibration is critical to patient safety and regulatory compliance, according to a release from Transcat. Transcat operates more than 30 calibration labs across North and Central America. "The acquisition of Southeastern Biomedical reinforces Transcat's strategy of deepening our presence in the Life Science sector, one of the most regulated and mission-critical end markets we serve," says Jaime Irick, president and CEO, in a release. "Southeastern's reputation for high quality and a customer-first approach supporting hospital networks throughout the southeastern region of the United States and beyond builds on our established leadership in biomedical calibration and will position us to service a much larger geography with a consistent focus on quality and timely service for our customers in these critical end markets." Southeastern Biomedical Associates owners Boyd Campbell and Greg Johnson will remain with Transcat to lead the growth of the combined biomedical business. "There was never a doubt that Transcat was the right partner to take our company to the next level of growth," says Greg Johnson, co-owner of Southeastern Biomedical Associates, in a release. "Transcat has developed a reputation in this industry for treating acquired employees and customers right, and for focusing on the key attributes and operating principles that have made Southeastern successful over time." The purchase price is subject to certain customary adjustments and holdback provisions. According to Transcat, the acquisition supports the company's fiscal 2027 outlook, which includes continued mergers and acquisitions and service gross margin expansion.

Yahoo Finance
Aug 13th, 2026
Transcat beats revenue estimates by 7.4% with 21.6% growth in calibration and distribution services

Transcat reported second-quarter results that beat Wall Street expectations, with revenue reaching $92.95 million against estimates of $86.55 million. The calibration and laboratory equipment company posted adjusted earnings per share of $0.51, surpassing analyst forecasts of $0.38. The company saw double-digit growth in both its Service and Distribution segments. CEO Jaime Irick attributed the performance to strong demand in regulated markets including life sciences, aerospace, and energy. During the earnings call, analysts focused on sustainability of growth drivers. Questions centred on end market performance, the company's rental business trajectory, and AI productivity improvements. Lake Street Capital asked about the rental business outlook, with CFO Thomas Barbato projecting high single-digit to low double-digit growth. Analysts also probed margin sustainability and market share potential. Operating margin declined to 5.5% from 7% year-on-year.

Yahoo Finance
Aug 5th, 2026
Transcat posts 27% service revenue growth, eyes high single-digit organic growth for FY2027

Transcat Inc reported strong fiscal Q1 2027 results, with consolidated revenue rising 22% to $92.9 million, driven by double-digit growth in both segments. Service revenue grew 27% year-over-year, including 13% organic growth — marking the 69th consecutive quarter of service revenue expansion. Service gross profit increased 31%, with margins expanding 90 basis points due to operational leverage and maturing customer relationships. The company's recent acquisition of SCM Metrology and Laboratories is progressing well, expanding its Central America presence. However, diluted earnings per share fell to $0.14, impacted by increased intangible asset amortisation, stock-based compensation, interest expense, and executive transition costs. Distribution segment gross margins decreased 380 basis points to 31.4% due to unusually high prior-year vendor rebates. Management expressed confidence in achieving high single-digit service organic growth for the full fiscal year, citing strong demand across life sciences, aerospace, and defence sectors.

Yahoo Finance
Aug 4th, 2026
Transcat reports Q2 revenue of $92.95M, up 21.6% year-on-year, beating estimates by 7.4%

Transcat reported second quarter 2026 results that exceeded revenue expectations, with sales reaching $92.95 million, up 21.6% year-on-year and 7.4% above analyst estimates of $86.55 million. The measurement equipment distributor posted non-GAAP earnings of $0.51 per share, beating consensus estimates of $0.38 by 35.1%. Adjusted EBITDA came in at $14 million, surpassing analyst expectations of $12.46 million by 12.4%, representing a 15.1% margin. Free cash flow improved to $4.84 million from negative $975,000 in the same quarter last year. However, operating margin declined to 4% from 7.1% in the prior-year quarter. Analysts forecast revenue growth of 6% over the next 12 months, a slowdown from the company's recent 14.5% two-year growth rate.